CURRENT REPORT OF FOREIGN ISSUER PURSUANT TO RULES 13A-16 AND 15D-16 AMENDMENTS

Company

Telix Pharmaceuticals Ltd

Filed

September 23, 2025

Period of Report

September 22, 2025

Accession Number

0002007191-25-000069